Coronavirus Disease-2019 (COVID-19)

The Kidney Health Initiative is committed to supporting the kidney community in it's efforts to protect people with kidney diseases from infection and innovate during the COVID-19 pandemic.

Partner Resources

Our partners at the US Food and Drug Administration (FDA) and ASN Alliance for Kidney Health are working with other government agencies and international partners to address COVID-19 and support the kidney community.

• FDA COVID-19 Webpage
• ASN COVID-19 Information

For Patients

COVID-19 resource pages for people with kidney diseases:

• COMBATCOVID.HHS.GOV
• COMBATECOVID.HHS.GOV (Español) 
  
• American Association of Kidney Patients
• American Kidney Fund
• National Kidney Foundation
• NephCure Kidney International

For Industry

• Including People with Kidney Diseases in COVID-19 Trials: Opportunity for Participation in Vaccine Trials, September 14, 2020
• Making the Case for Change: Including People with Kidney Diseases in COVID-19 Trials, May 14, 2020
• Accelerating Technology Development During a Pandemic to Bring More People with Kidney Failure Home, May 8, 2020

For Clinical Trialists and Clinicians

• COMBATCOVID.HHS.GOV
• COMBATECOVID.HHS.GOV (Español)
  
• Kidney Week Reimagined session: COVID-19 Clinical Trials: The Critical Need to Include People with Kidney Diseases, October 2020
• Moderna Vaccine Trial Protocol , September 2020
• Pfizer Vaccine Trial Protocol , September 2020
• AstraZeneca Vaccine Trial Protocol , September 19, 2020
• Janssen Vaccine Trial Protocol , September 23, 2020
• NIH Corona Virus Prevention Network
• FasterCures COVID-19 Treatment and Vaccine Tracker
• Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic, FDA, Updated September 21, 2020
• Impacts of COVID-19 on the Conduct of Clinical Trials, NIH Collaboratory, March 24
• Guidance for Clinical Trials Affected by COVID-19, NIH, March 16 For People with Kidney Disease
• Current List of COVID-19 Trials on ClinicalTrials.org